JP2006504751A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006504751A5 JP2006504751A5 JP2004544592A JP2004544592A JP2006504751A5 JP 2006504751 A5 JP2006504751 A5 JP 2006504751A5 JP 2004544592 A JP2004544592 A JP 2004544592A JP 2004544592 A JP2004544592 A JP 2004544592A JP 2006504751 A5 JP2006504751 A5 JP 2006504751A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- hydrogen
- parathyroid
- lower alkyl
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@](CCC[C@@](*)(*1)C1C[C@](*C(C[C@@](C(C)(C)C([C@@]1C)=O)O)=O)C(C)=Cc2c[s]c(*)n2)C1=O Chemical compound C[C@](CCC[C@@](*)(*1)C1C[C@](*C(C[C@@](C(C)(C)C([C@@]1C)=O)O)=O)C(C)=Cc2c[s]c(*)n2)C1=O 0.000 description 5
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41859202P | 2002-10-15 | 2002-10-15 | |
| PCT/IB2003/004514 WO2004035050A1 (en) | 2002-10-15 | 2003-10-13 | Use of epothilone derivatives for the treatment of hyperparathyroidism |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006504751A JP2006504751A (ja) | 2006-02-09 |
| JP2006504751A5 true JP2006504751A5 (https=) | 2006-11-30 |
| JP4672368B2 JP4672368B2 (ja) | 2011-04-20 |
Family
ID=32107949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004544592A Expired - Fee Related JP4672368B2 (ja) | 2002-10-15 | 2003-10-13 | 副甲状腺機能亢進症の処置のためのエポシロン誘導体の使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20060142354A1 (https=) |
| EP (1) | EP1553938B1 (https=) |
| JP (1) | JP4672368B2 (https=) |
| CN (1) | CN1297269C (https=) |
| AT (1) | ATE350034T1 (https=) |
| AU (1) | AU2003267751A1 (https=) |
| BR (1) | BR0315293A (https=) |
| CA (1) | CA2501717C (https=) |
| CY (1) | CY1106385T1 (https=) |
| DE (1) | DE60310975T2 (https=) |
| DK (1) | DK1553938T3 (https=) |
| ES (1) | ES2279139T3 (https=) |
| PT (1) | PT1553938E (https=) |
| SI (1) | SI1553938T1 (https=) |
| WO (1) | WO2004035050A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60330407D1 (de) | 2002-08-23 | 2010-01-14 | Sloan Kettering Inst Cancer | Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1155689B1 (en) * | 1993-07-19 | 2006-09-20 | Angiotech Pharmaceuticals, Inc. | Anti-angiogenic stents and methods of their preparation |
| DK1367057T3 (da) * | 1996-11-18 | 2009-01-19 | Biotechnolog Forschung Gmbh | Epothiloner E og F |
| US6380394B1 (en) * | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
| SK287775B6 (sk) * | 1998-02-05 | 2011-09-05 | Novartis Ag | Farmaceutická formulácia obsahujúca epothilon, infúzny roztok a použitie farmaceutickej formulácie |
| US6302838B1 (en) * | 1998-02-25 | 2001-10-16 | Novartis Ag | Cancer treatment with epothilones |
-
2003
- 2003-10-13 CA CA2501717A patent/CA2501717C/en not_active Expired - Fee Related
- 2003-10-13 BR BR0315293-6A patent/BR0315293A/pt not_active IP Right Cessation
- 2003-10-13 SI SI200330741T patent/SI1553938T1/sl unknown
- 2003-10-13 PT PT03748446T patent/PT1553938E/pt unknown
- 2003-10-13 US US10/530,855 patent/US20060142354A1/en not_active Abandoned
- 2003-10-13 ES ES03748446T patent/ES2279139T3/es not_active Expired - Lifetime
- 2003-10-13 EP EP03748446A patent/EP1553938B1/en not_active Expired - Lifetime
- 2003-10-13 CN CNB200380101281XA patent/CN1297269C/zh not_active Expired - Fee Related
- 2003-10-13 AU AU2003267751A patent/AU2003267751A1/en not_active Abandoned
- 2003-10-13 JP JP2004544592A patent/JP4672368B2/ja not_active Expired - Fee Related
- 2003-10-13 WO PCT/IB2003/004514 patent/WO2004035050A1/en not_active Ceased
- 2003-10-13 AT AT03748446T patent/ATE350034T1/de active
- 2003-10-13 DK DK03748446T patent/DK1553938T3/da active
- 2003-10-13 DE DE60310975T patent/DE60310975T2/de not_active Expired - Lifetime
-
2007
- 2007-03-15 CY CY20071100363T patent/CY1106385T1/el unknown
-
2011
- 2011-03-01 US US13/037,989 patent/US20110152329A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2003130058A (ru) | Комбинации, включающие антидиарейный агент и эпотилон или производные эпотилона | |
| JP2013501731A5 (https=) | ||
| NZ527113A (en) | Rapid-onset medicament for the treatment of sexual dysfunction | |
| RU2006109467A (ru) | Способы лечения рака с использованием ингибиторов hdac | |
| JP2010500376A5 (https=) | ||
| RU2000113729A (ru) | Гетероциклические соединения для ингибирования секреции желудочной кислоты, способы их получения и их фармацевтические компоозиции | |
| JP2009504763A5 (https=) | ||
| WO2010081817A1 (en) | Method for treating colorectal cancer | |
| JP2006506443A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2019515884A5 (https=) | ||
| JP2006503850A5 (https=) | ||
| JP2006507220A5 (https=) | ||
| JP2008520544A5 (ja) | 癌関連疲労の治療または予防のための医薬の製造への使用方法 | |
| JP2006514092A5 (https=) | ||
| JP2020532562A5 (https=) | ||
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| RU2010123028A (ru) | Кортикостероиды для лечения диареи, индуцированной эпотилоном или производным эпотилона | |
| JP2003519228A5 (https=) | ||
| ES2405323T3 (es) | Tratamiento de melanoma | |
| JPH10147529A5 (https=) | ||
| RU2004131214A (ru) | Способы лечения когнитивных расстройств | |
| CN103327975A (zh) | 用于治疗多形性成胶质母细胞瘤的含有马西替坦的组合物 | |
| JP2012525411A5 (https=) | ||
| JP4672257B2 (ja) | エポチロンを含む組成物およびカルチノイド症候群の治療のためのそれらの使用 |